Genome-scale CRISPR-Cas9 knockout screening in human cells

Cited by (1,041)

Items 101–200 of 1,041

1. Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targets
   Subash C. Gupta, Yashoda Nandan Tripathi · 2016 · International Journal of Cancer
2. Screening out irrelevant cell-based models of disease
   Horvath, Peter, Aulner, Nathalie, Bickle, Marc, Davies, Anthony M., Nery, Elaine Del, Ebner, Daniel, Montoya, Maria C., Östling, Päivi, Pietiäinen, Vilja, Price, Leo S. et al. · 2016 · Nature Reviews Drug Discovery
3. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
   Wei Li, Johannes Köster, Han Xu, Chen-Hao Chen, Tengfei Xiao, Jun S. Liu, Myles A Brown, X. Shirley Liu · 2015 · Genome biology
4. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
   K. Han, E. Jeng, G. Hess, D. Morgens, Amy Li, M. Bassik · 2017 · Nature Biotechnology
5. Induced Pluripotent Stem Cells Meet Genome Editing
   Hockemeyer, Dirk, Jaenisch, Rudolf · 2016 · Cell Stem Cell
6. An enhanced CRISPR repressor for targeted mammalian gene regulation
   Nan Cher Yeo, Alejandro Chavez, Alissa Lance‐Byrne, Yingleong Chan, David J Menn, Denitsa Milanova, Chih‐Chung Kuo, Xiaoge Guo, Sumana Sharma, Angela Tung et al. · 2018 · Nature Methods
7. A highly specific SpCas9 variant is identified by in vivo screening in yeast
   Casini, Antonio, Olivieri, Michele, Petris, Gianluca, Montagna, Claudia, Reginato, Giordano, Maule, Giulia, Lorenzin, Francesca, Prandi, Davide, Romanel, Alessandro, Demichelis, Francesca et al. · 2018 · Nature Biotechnology
8. CRISPR-Cas: biology, mechanisms and relevance
   Frank Hille, Emmanuelle Charpentier · 2016 · Philosophical Transactions of the Royal Society B Biological Sciences
9. YAP/TAZ Signaling and Resistance to Cancer Therapy
   Nguyen, Chan D.K., Yi, Chunling · 2019 · Trends in Cancer
10. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
    Liu, Xinjian, Bao, Xuhui, Hu, Mengjie, Chang, Hanman, Jiao, Meng, Cheng, Jin, Xie, Liyi, Huang, Qian, Li, Fang, Li, Chuan-Yuan · 2020 · Nature
11. CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
    Klann, Tyler S, Black, Joshua B, Chellappan, Malathi, Safi, Alexias, Song, Lingyun, Hilton, Isaac B, Crawford, Gregory E, Reddy, Timothy E, Gersbach, Charles A · 2017 · Nature Biotechnology
12. Synthetic lethality as an engine for cancer drug target discovery
    Alan Huang, Levi A. Garraway, Alan Ashworth, Barbara L. Weber · 2019 · Nature Reviews Drug Discovery
13. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
    Wang, Si-Wei, Gao, Chao, Zheng, Yi-Min, Yi, Li, Lu, Jia-Cheng, Huang, Xiao-Yong, Cai, Jia-Bin, Zhang, Peng-Fei, Cui, Yue-Hong, Ke, Ai-Wu · 2022 · Molecular Cancer
14. Efficient Gene Disruption in Diverse Strains of Toxoplasma gondii Using CRISPR/CAS9
    Bang Shen, Kevin M. Brown, Tobie D. Lee, L. David Sibley · 2014 · mBio
15. Glycosylase base editors enable C-to-A and C-to-G base changes
    Dongdong Zhao, Ju Li, Siwei Li, Xiuqing Xin, Muzi Hu, Marcus A. Price, Susan J. Rosser, Changhao Bi, Xueli Zhang · 2020 · Nature Biotechnology
16. Massively parallel Cas13 screens reveal principles for guide RNA design
    Wessels, Hans-Hermann, Méndez-Mancilla, Alejandro, Guo, Xinyi, Legut, Mateusz, Daniloski, Zharko, Sanjana, Neville E. · 2020 · Nature Biotechnology
17. Role of Merlin/NF2 inactivation in tumor biology
    Alejandra M. Petrilli, Cristina Fernández‐Valle · 2015 · Oncogene
18. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
    Wang, Xiaoling, Wang, Yebo, Wu, Xiwei, Wang, Jinhui, Wang, Yingjia, Qiu, Zhaojun, Chang, Tammy, Huang, He, Lin, Ren-Jang, Yee, Jiing-Kuan · 2015 · Nature Biotechnology
19. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
    Jonathan Leo Schmid-Burgk, Dhruv Chauhan, Tobias Schmidt, Thomas S. Ebert, Julia Reinhardt, Elmar Endl, Veit Hornung · 2015 · Journal of Biological Chemistry
20. DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
    Laura Lau, Elizabeth E. Gray, Rebecca L. Brunette, Daniel B. Stetson · 2015 · Science
21. Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
    Stephen J. Pettitt, Dragomir B. Krastev, Inger Brandsma, Amy Dréan, Feifei Song, Radoslav Aleksandrov, Maria I. Harrell, Malini R. Menon, Rachel Brough, James Campbell et al. · 2018 · Nature Communications
22. Am I ready for CRISPR? A user's guide to genetic screens
    Doench, John G. · 2018 · Nature Reviews Genetics
23. Mxra8 is a receptor for multiple arthritogenic alphaviruses
    Zhang, Rong, Kim, Arthur S., Fox, Julie M., Nair, Sharmila, Basore, Katherine, Klimstra, William B., Rimkunas, Rebecca, Fong, Rachel H., Lin, Hueylie, Poddar, Subhajit et al. · 2018 · Nature
24. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute
    Binbin Wang, Mei Wang, Wubing Zhang, Tengfei Xiao, Chen-Hao Chen, Alexander Wu, Feizhen Wu, Nicole C. Traugh, Xiaoqing Wang, Ziyi Li et al. · 2019 · Nature Protocols
25. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1
    Zhao, Baoyu, Du, Fenglei, Xu, Pengbiao, Shu, Chang, Sankaran, Banumathi, Bell, Samantha L., Liu, Mengmeng, Lei, Yuanjiu, Gao, Xinsheng, Fu, Xiaofeng et al. · 2019 · Nature
26. Cornerstones of CRISPR–Cas in drug discovery and therapy
    Christof Fellmann, Benjamin G. Gowen, Pei‐Chun Lin, Jennifer A. Doudna, Jacob E. Corn · 2016 · Nature Reviews Drug Discovery
27. Hypoxia as a therapy for mitochondrial disease
    Isha H. Jain, L. Zazzeron, Rahul Goli, Kristen Alexa, Stephanie Schatzman-Bone, Harveen Dhillon, Olga Goldberger, Jun Peng, Ophir Shalem, Neville E. Sanjana et al. · 2016 · Science
28. A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks
    Parnas, Oren, Jovanovic, Marko, Eisenhaure, Thomas M., Herbst, Rebecca H., Dixit, Atray, Ye, Chun Jimmie, Przybylski, Dariusz, Platt, Randall J., Tirosh, Itay, Sanjana, Neville E. et al. · 2015 · Cell
29. CRISPR in cancer biology and therapy
    Alyna Katti, Bianca Jay Diaz, Christina M. Caragine, Neville E. Sanjana, Lukas E. Dow · 2022 · Nature reviews. Cancer
30. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library
    Shiyou Zhu, Wei Li, Jingze Liu, Chen-Hao Chen, Qi Liao, Ping Xu, Han Xu, Tengfei Xiao, Zhongzheng Cao, Jingyu Peng et al. · 2016 · Nature Biotechnology
31. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
    Meromit Singer, Chao Wang, Le Cong, Nemanja Despot Marjanovic, Monika S. Kowalczyk, Huiyuan Zhang, Jackson Nyman, Kaori Sakuishi, Sema Kurtuluş, David G. Gennert et al. · 2016 · Cell
32. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood
    Julia Joung, J Engreitz, Silvana Konermann, Omar O. Abudayyeh, Vanessa K. Verdine, François Aguet, Jonathan S. Gootenberg, Neville E. Sanjana, Jason B. Wright, Charles P. Fulco et al. · 2017 · Nature
33. Genome-Editing Technologies: Principles and Applications
    Thomas Gaj, Shannon J. Sirk, Sailan Shui, Jia Liu · 2016 · Cold Spring Harbor Perspectives in Biology
34. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
    Bastiaan Evers, Katarzyna Jastrzebski, Jeroen P M Heijmans, Wipawadee Grernrum, Roderick L. Beijersbergen, René Bernards · 2016 · Nature Biotechnology
35. Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens
    Marceau, Caleb D., Puschnik, Andreas S., Majzoub, Karim, Ooi, Yaw Shin, Brewer, Susan M., Fuchs, Gabriele, Swaminathan, Kavya, Mata, Miguel A., Elias, Joshua E., Sarnow, Peter et al. · 2016 · Nature
36. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells
    Harveer Dev, Ting-Wei Will Chiang, Chloé Lescale, Inge de Krijger, Alistair G. Martin, Domenic Pilger, Julia Coates, Matylda Sczaniecka-Clift, Wenming Wei, Matthias Ostermaier et al. · 2018 · Nature Cell Biology
37. Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
    Li, Ling, Hu, Shuo, Chen, Xiaoyuan · 2018 · Biomaterials
38. Thermo-triggered release of CRISPR-Cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy
    Wang, Peng, Zhang, Lingmin, Zheng, Wenfu, Cong, Liman, Guo, Zhaorong, Xie, Yangzhouyun, Wang, Le, Tang, Rongbing, Feng, Qiang, Hamada, Yoh et al. · 2018 · Angewandte Chemie International Edition
39. Rapid modelling of cooperating genetic events in cancer through somatic genome editing
    Francisco J. Sánchez Rivera, Thales Y. Papagiannakopoulos, Rodrigo Romero, Tuomas Tammela, Matthew R. Bauer, Arjun J. Bhutkar, Nikhil S. Joshi, Lakshmipriya Subbaraj, Roderick Terry Bronson, Wen Xue et al. · 2014 · Nature
40. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics
    Traver Hart, Kevin R. Brown, Fabrice Sircoulomb, Robert K. Rottapel, Jason Moffat · 2014 · Molecular Systems Biology
41. Expanding the Biologist’s Toolkit with CRISPR-Cas9
    Samuel H. Sternberg, Jennifer A. Doudna · 2015 · Molecular Cell
42. Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
    David W. Morgens, Richard M. Deans, Amy Li, Michael Cory Bassik · 2016 · Nature Biotechnology
43. A multiprotein supercomplex controlling oncogenic signalling in lymphoma
    James D. Phelan, Ryan M. Young, Daniel E. Webster, Sandrine Roulland, George W. Wright, Monica Kasbekar, Arthur L. Shaffer, Michele Ceribelli, James Q. Wang, Roland Schmitz et al. · 2018 · Nature
44. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy
    Yuanyuan Xu, Zhanjun Li · 2020 · Computational and Structural Biotechnology Journal
45. Applications of the CRISPR-Cas9 system in cancer biology
    Sánchez-Rivera, Francisco J., Jacks, Tyler · 2015 · Nature Reviews Cancer
46. LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern
    Tian-Tian Sun, Jie He, Qian Liang, Lin-Lin Ren, Ting-Ting Yan, Ta-Chung Yu, Jia‐Yin Tang, Yu-Jie Bao, Ye Hu, Yanwei Lin et al. · 2016 · Cancer Discovery
47. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
    Bengtsson, Niclas E., Hall, John K., Odom, Guy L., Phelps, Michael P., Andrus, Colin R., Hawkins, R. David, Hauschka, Stephen D., Chamberlain, Joel R., Chamberlain, Jeffrey S. · 2017 · Nature Communications
48. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9
    Gözde Korkmaz, Rui Lopes, Alejandro Pineiro Ugalde, Ekaterina Nevedomskaya, Ruiqi Han, Ksenia Myacheva, Wilbert T. Zwart, Ran Elkon, Reuven Agami · 2016 · Nature Biotechnology
49. Towards a comprehensive catalogue of validated and target-linked human enhancers
    Gasperini, Molly, Tome, Jacob M., Shendure, Jay · 2020 · Nature Reviews Genetics
50. SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability
    Lei Li, Lan Shi, Shangda Yang, Ruorong Yan, Di Zhang, Jianguo Yang, Lin He, Wanjin Li, Xia Yi, Luyang Sun et al. · 2016 · Nature Communications
51. Variant interpretation: functional assays to the rescue
    Starita, Lea M., Ahituv, Nadav, Dunham, Maitreya J., Kitzman, Jacob O., Roth, Frederick P., Seelig, Georg, Shendure, Jay, Fowler, Douglas M. · 2017 · The American Journal of Human Genetics
52. In vivo high-throughput profiling of CRISPR-Cpf1 activity
    Kim, Hui K, Song, Myungjae, Lee, Jinu, Menon, A Vipin, Jung, Soobin, Kang, Young-Mook, Choi, Jae W, Woo, Euijeon, Koh, Hyun C, Nam, Jin-Wu et al. · 2017 · Nature Methods
53. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
    Ami M. Kabadi, David G. Ousterout, Isaac B. Hilton, Charles A. Gersbach · 2014 · Nucleic Acids Research
54. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
    Belk, Julia A., Yao, Winnie, Ly, Nghi, Freitas, Katherine A., Chen, Yan-Ting, Shi, Quanming, Valencia, Alfredo M., Shifrut, Eric, Kale, Nupura, Yost, Kathryn E. et al. · 2022 · Cancer Cell
55. Posttranscriptional m6A Editing of HIV-1 mRNAs Enhances Viral Gene Expression
    Edward M. Kennedy, Hal P. Bogerd, Anand V. R. Kornepati, Dong Kang, Delta Ghoshal, Joy B. Marshall, Brigid Chiyoko Poling, Kevin Tsai, Nandan S. Gokhale, Stacy M. Horner et al. · 2016 · Cell Host & Microbe
56. WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system
    Nathan W. Wong, Weijun Liu, Xiaowei Wang · 2015 · Genome biology
57. Selection of chromosomal DNA libraries using a multiplex CRISPR system
    Owen W. Ryan, Jeffrey M. Skerker, Matthew J. Maurer, Xin Li, Jordan C. Tsai, Snigdha Poddar, Michael E. Lee, Will DeLoache, John E. Dueber, Adam P. Arkin et al. · 2014 · eLife
58. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
    Martin Kampmann · 2017 · ACS Chemical Biology
59. Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
    Guièze, Romain, Liu, Vivian M., Rosebrock, Daniel, Jourdain, Alexis A., Hernández-Sánchez, María, Martinez Zurita, Aina, Sun, Jing, Ten Hacken, Elisa, Baranowski, Kaitlyn, Thompson, Philip A. et al. · 2019 · Cancer Cell
60. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses
    Rong Zhang, Jonathan J. Miner, Matthew J. Gorman, Keiko Rausch, Holly R. Ramage, James P. White, Adam Zuiani, Ping Zhang, Estefanı́a Fernández, Qiang Zhang et al. · 2016 · Nature
61. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
    Kim, Dohoon, Fiske, Brian P., Birsoy, Kivanc, Freinkman, Elizaveta, Kami, Kenjiro, Possemato, Richard L., Chudnovsky, Yakov, Pacold, Michael E., Chen, Walter W., Cantor, Jason R. et al. · 2015 · Nature
62. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency
    Ying Dang, Gengxiang Jia, Jennie Choi, Hongming Ma, Edgar Anaya, Chunting Ye, Premlata Shankar, Haoquan Wu · 2015 · Genome biology
63. Genome-wide mapping of mutations at single-nucleotide resolution for protein, metabolic and genome engineering
    Andrew D. Garst, Marcelo C. Bassalo, Gur Pines, Sean A. Lynch, Andrea L. Halweg‐Edwards, Rongming Liu, Liya Liang, Zhiwen Wang, Ramsey I. Zeitoun, William G. Alexander et al. · 2016 · Nature Biotechnology
64. Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics
    George Savidis, William M. McDougall, Paul Meraner, Jill M. Perreira, Jocelyn M. Portmann, Gaia Trincucci, Sinu P. John, Aaron M. Aker, Nicholas Renzette, Douglas R. Robbins et al. · 2016 · Cell Reports
65. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers
    Petra Schwertman, Simon Bekker‐Jensen, Niels Mailand · 2016 · Nature Reviews Molecular Cell Biology
66. Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
    David W. Morgens, Michael Wainberg, Evan A. Boyle, Oana Ursu, Carlos L. Araya, C. Kimberly Tsui, Michael Seamus Haney, Gaelen T. Hess, Kyuho Han, Edwin E. Jeng et al. · 2017 · Nature Communications
67. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
    Shruti Marwaha, Joshua W. Knowles, Euan Angus Ashley · 2022 · Genome Medicine
68. Screening for functional circular RNAs using the CRISPR–Cas13 system
    Siqi Li, Xiang Li, Wei Xue, Lin Zhang, Liang-Zhong Yang, Shi-Meng Cao, Yun-Ni Lei, Chu-Xiao Liu, Si-Kun Guo, Lin Shan et al. · 2020 · Nature Methods
69. Rapid reverse genetic screening using CRISPR in zebrafish
    Arish N Shah, Crystal F. Davey, Alex C Whitebirch, Adam C. Miller, Cecilia B. Moens · 2015 · Nature Methods
70. Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets
    Dinesh Kumar Barupal, Oliver Fiehn · 2017 · Scientific Reports
71. Mutant p53 Suppresses Innate Immune Signaling to Promote Tumorigenesis
    Monisankar Ghosh, Suchandrima Saha, Julie A. Bettke, Rachana Nagar, Alejandro Parrales, Tomoo Iwakuma, Adrianus W. M. van der Velden, Luis A. Martinez · 2020 · Cancer Cell
72. scTenifoldKnk: An Efficient Virtual Knockout Tool for Gene Function Predictions via Single-Cell Gene Regulatory Network Perturbation
    Daniel Osorio, Yan Zhong, Guanxun Li, Qian Xu, Yongjian Yang, Andrew Hillhouse, Jingshu Chen, Laurie A. Davidson, Yanan Tian, Robert S. Chapkin et al. · 2021 · Patterns
73. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
    Benjamin H. Lok, Eric E. Gardner, Valentina E. Schneeberger, Ai Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A. Teicher, Nadeem Riaz, Simon N. Powell et al. · 2016 · Clinical Cancer Research
74. Optical Pooled Screens in Human Cells
    Feldman, David, Singh, Avtar, Schmid-Burgk, Jonathan L., Carlson, Rebecca J., Mezger, Anja, Garrity, Anthony J., Zhang, Feng, Blainey, Paul C. · 2019 · Cell
75. Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells*
    Matthew C. Canver, Daniel E. Bauer, Abhishek Dass, Yvette Y. Yien, Jacky Chung, Takeshi Masuda, Takahiro Maeda, Barry H. Paw, Stuart H. Orkin · 2014 · Journal of Biological Chemistry
76. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
    Wang, Eric, Lu, Sydney X., Pastore, Alessandro, Chen, Xufeng, Imig, Jochen, Chun-Wei Lee, Stanley, Hockemeyer, Kathryn, Ghebrechristos, Yohana E., Yoshimi, Akihide, Inoue, Daichi et al. · 2019 · Cancer Cell
77. Massively parallel assessment of human variants with base editor screens
    Hanna, Ruth E., Hegde, Mudra, Fagre, Christian R., DeWeirdt, Peter C., Sangree, Annabel K., Szegletes, Zsofia, Griffith, Audrey, Feeley, Marissa N., Sanson, Kendall R., Baidi, Yossef et al. · 2021 · Cell
78. CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations
    Kuscu, Cem, Parlak, Mahmut, Tufan, Turan, Yang, Jiekun, Szlachta, Karol, Wei, Xiaolong, Mammadov, Rashad, Adli, Mazhar · 2017 · Nature Methods
79. Challenges and emerging directions in single-cell analysis
    Guo‐Cheng Yuan, Long Cai, Michael B. Elowitz, Tariq Enver, Guoping Fan, Guoji Guo, Rafael A. Irizarry, Peter V. Kharchenko, Junhyong Kim, Stuart H. Orkin et al. · 2017 · Genome biology
80. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing
    Fei Teng, Yiwen Chen, Tengfei Xiao, Wei Li, Laura Cato, Peng Zhang, Maura B. Cotter, Michaela Bowden, Rosina T. Lis, Shuang George Zhao et al. · 2017 · Proceedings of the National Academy of Sciences
81. Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
    Hsin‐Kai Liao, Ying Gu, Arturo Diaz, John M. Marlett, Yuta Takahashi, Mo Li, Keiichiro Suzuki, Ruo Xu, Tomoaki Hishida, Chan-Jung Chang et al. · 2015 · Nature Communications
82. Deep sequencing of 10,000 human genomes
    Amalio Telenti, Levi Pierce, William Biggs, Julia di Iulio, Emily Wong, Martin M. Fabani, Ewen F. Kirkness, Ahmed Moustafa, Naisha Shah, Chao Xie et al. · 2016 · Proceedings of the National Academy of Sciences
83. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
    Dong, Matthew B., Wang, Guangchuan, Chow, Ryan D., Ye, Lupeng, Zhu, Lvyun, Dai, Xiaoyun, Park, Jonathan J., Kim, Hyunu R., Errami, Youssef, Guzman, Christopher D. et al. · 2019 · Cell
84. Recent advances in metabolic engineering of Saccharomyces cerevisiae: New tools and their applications
    Jiazhang Lian, Shekhar Mishra, Huimin Zhao · 2018 · Metabolic Engineering
85. SLC19A1 is an importer of the immunotransmitter cGAMP.
    Ritchie, Christopher, Cordova, Anthony F., Hess, Gaelen T., Bassik, Michael C., Li, Lingyin · 2019 · Molecular Cell
86. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
    Ryan Jin-hyung Park, Tim Wang, Dylan Koundakjian, Judd F. Hultquist, Pedro A. Lamothe, Blandine Monel, Kathrin Schumann, Haiyan Yu, Kevin M Krupzcak, Wilfredo F. García-Beltrán et al. · 2016 · Nature Genetics
87. RNAi screening comes of age: improved techniques and complementary approaches
    Stephanie Elizabeth Mohr, Jennifer A. Smith, Caroline E. Shamu, Ralph A. Neumüller, Norbert Perrimon · 2014 · Nature Reviews Molecular Cell Biology
88. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis
    Jin‐Fei Lin, Peishan Hu, Yiyu Wang, Yue‐Tao Tan, Kai Yu, Kun Lun Liao, Qi‐Nian Wu, Ting Li, Meng Qi, Junzhong Lin et al. · 2022 · Signal Transduction and Targeted Therapy
89. Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning
    Wang, Daqi, Zhang, Chengdong, Wang, Bei, Li, Bin, Wang, Qiang, Liu, Dong, Wang, Hongyan, Zhou, Yan, Shi, Leming, Lan, Feng et al. · 2019 · Nature Communications
90. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages
    Pastore, Nunzia, Brady, Owen A., Diab, Heba I., Martina, José A., Sun, Lu, Huynh, Tuong, Lim, Jeong-A, Zare, Hossein, Raben, Nina, Ballabio, Andrea et al. · 2016 · Autophagy
91. Somatic inflammatory gene mutations in human ulcerative colitis epithelium
    Kosaku Nanki, Masayuki Fujii, Mariko Shimokawa, Mami Matano, Shingo Nishikori, Shoichi Date, Ai Takano, Kohta Toshimitsu, Yuki Ohta, Sirirat Takahashi et al. · 2019 · Nature
92. Epigenetic regulation of T cell exhaustion
    Julia A. Belk, Bence Dániel, Ansuman T. Satpathy · 2022 · Nature Immunology
93. Transcription control by the ENL YEATS domain in acute leukaemia
    Michael A. Erb, Thomas G. Scott, Bin E. Li, Huafeng Xie, Joshiawa Paulk, Hyuk‐Soo Seo, Amanda Souza, Justin M. Roberts, Shiva Dastjerdi, Dennis L. Buckley et al. · 2017 · Nature
94. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
    Kim, Jiyeon, Hu, Zeping, Cai, Ling, Li, Kailong, Choi, Eunhee, Faubert, Brandon, Bezwada, Divya, Rodriguez-Canales, Jaime, Villalobos, Pamela, Lin, Yu-Fen et al. · 2017 · Nature
95. CRISPR-Cas9 system: A new-fangled dawn in gene editing
    Darshana Gupta, Oindrila Bhattacharjee, Drishti Mandal, Madhab Kumar Sen, Dhritiman Dey, Adhiraj Dasgupta, Tawsif Ahmed Kazi, Rahul Kumar Gupta, Senjuti Sinharoy, Krishnendu Acharya et al. · 2019 · Life Sciences
96. Histidine catabolism is a major determinant of methotrexate sensitivity
    Naama Kanarek, Heather R. Keys, Jason R. Cantor, Caroline A. Lewis, Sze Ham Chan, Tenzin Kunchok, Monther Abu-Remaileh, Elizaveta Freinkman, Lawrence D. Schweitzer, David M. Sabatini · 2018 · Nature
97. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism
    Pin Wang, Junfang Xu, Yujia Wang, Xuetao Cao · 2017 · Science
98. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
    Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim, Shunsuke Kitajima, Russell William Jenkins, Camilla Laulund Christensen, Marco Campisi, Yanan Kuang, Yanxi Zhang, Evisa Gjini et al. · 2018 · Nature Medicine
99. TFEB and TFE3 are novel components of the integrated stress response
    Martina, José A, Diab, Heba I, Brady, Owen A, Puertollano, Rosa · 2016 · The EMBO Journal
100. Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus
     Yasuhiro Kato, JeongHoon Park, Hyota Takamatsu, Hachirou Konaka, Wataru Aoki, Shunsuke Aburaya, Mitsuyoshi Ueda, Masayuki Nishide, Shohei Koyama, Yoshitomo Hayama et al. · 2018 · Annals of the Rheumatic Diseases